-
SKYA share price: temporarily unavailable. We are sorry, but this information is temporarily unavailable.
-
SKYA stock price change: temporarily unavailable. We are sorry, but this information is temporarily unavailable.
-
SKYA market open/close: temporarily unavailable. We are sorry, but this information is temporarily unavailable.
Key terms
About SKYA
SkyAI, Inc. is a medical device and pharmaceutical packaging company, which engages in the development and manufacturing of innovative drug delivery systems. It also focuses on low waste, and ultra-low waste syringe technologies that incorporate both passive and active safety features. The company was founded by Alan R. Blackman and Barry B. Berler on December 16, 2017 and is headquartered in Melville, NY.
-
Market cap: $74.91M
A market capitalization up to $300 million places SKYA in the micro-capitalization category.
Key terms
Smart score
Latest SKYA news
No recent TipRanks articles are available for SKYA
SKYA Financials
-
SKYA total_revenue: currently unavailable. Sorry, we currently don't have enough data to create an insight.
-
Net income: -$281.42M (1Y), -$86.24M (Q1)
Net Income decreased 2927.3% since last year and increased 49.38% since last quarter.
-
Earnings per share: -$11.12 (1Y), -$1.19 (Q1)
EPS increased 99.5% since last year and increased 81.02% since last quarter.
Key terms
SKYA Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
SKYA Competitors
-
How competitors are chosen
SKYA's competitors are included in the Health Technology sector and Medical Specialties group
-
Market cap: $74.91M
A market capitalization up to $300 million places SKYA in the micro-capitalization category.
